Test: Avian paramyxovirus -1 (Newcastle disease virus)

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications

 

a)   Test method

OIE Manual of Diagnostic Test and Vaccines for Terrestrial Animals, Chapter 3.3.14 ( Version adopted in May 2012)

b)   Test type

Qualitative

c)    Sample type

Swabs: Cloacal and oropharyngeal

Tissues: Brain, trachea, heart, lung, spleen, liver, intestine and kidney

d)   Sample Volume/Amount

Swabs must be send in viral transport medium which can be collected from CVRL. Appropriate amount of  tissues/organs

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ section ‘’Sending a sample’’

f)    TAT

7 - 14 working days

g)   Results

Refer ‘CVRL- Guidelines’,  section ‘’Results’’

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Virus isolated or no virus isolated

Test: Influenza A virus (All avian Influenza strains including H5, H7 & H9)

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications

 

a)   Test method

OIE Manual of Diagnostic Test and Vaccines for Terrestrial Animals, Chapter 3.3.4   ( Version adopted in May 2015)

b)   Test type

Qualitative

c)    Sample type

Swabs: Cloacal and oropharyngeal

Tissues: Brain, trachea, heart, lung, spleen, liver, intestine and kidney

d)   Sample Volume/Amount

Swabs must be send in viral transport medium which can be collected from CVRL. Appropriate amount of  tissues/organs

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ section ‘’Sending a sample’’

f)    TAT

7 - 14 working days

g)   Results

Refer ‘CVRL- Guidelines’,  section ‘’Results’’

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Virus isolated or no virus isolated

Test: Equine Arteritis virus (EAV)

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications

 

a)   Test method

OIE Manual of Diagnostic Test and Vaccines for Terrestrial Animals, Chapter 3.5.10  (Version adopted in May 2013)

b)   Test type

Qualitative

c)    Sample type

Semen

d)   Sample Volume/Amount

Around 10 ml

Refer ‘CVRL- Guidelines’,  section ‘’Submission of Samples 3.3.10.4 Semen sampling for Equine Arteritis Virus isolation’’

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ section ‘’Sending a sample’’

f)    TAT

7 - 21 working days

g)   Results

Refer ‘CVRL- Guidelines’,  section ‘’Results’’

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Virus isolated or no virus isolated

Test: Equine Influenza virus (EI)

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications

 

a)   Test method

OIE Manual of Diagnostic Test and Vaccines for Terrestrial Animals, Chapter 3.5.7 (Version adopted in May 2019)

b)   Test type

Qualitative

c)    Sample type

Swab: Nasal

Transtracheal lavage

d)   Sample Volume/Amount

Swabs must be send in viral transport medium which can be collected from CVRL. Transtracheal lavage - 10 ml

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ section ‘’Sending a sample’’

f)    TAT

7 - 14 working days

g)   Results

Refer ‘CVRL- Guidelines’,  section ‘’Results’’

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Virus isolated or no virus isolated

Test: Influenza A (Rapid Immunochromatographic Assay)

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications

 

a)        Test method

Kit Instruction

b)        Test type

Qualitative

c)         Sample type

 Nasopharyngeal washes/aspirates, oropharyngeal and throat swabs in viral transport medium, which can be collected from CVRL.

d)        Sample Volume/Amount

Refer ‘CVRL- Guidelines’, section “Guidelines for Submission of Samples 3.3.10.2 Specimen Collection for Rapid Test for Influenza A”

e)        Sample submission

CVRL does not conduct site visit and sampling. Refer ‘CVRL- Guidelines’, section ‘’Sending a sample’’

f)         TAT

1 - 2 working days

g)        Results

Refer ‘CVRL- Guidelines’, section ‘’Results’’

h)        Measurement of Uncertainty (MU)

N/A

i)          Expression of result

Positive or Negative

Test: Equine Viral Arteritis (EVA) – VNT

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications

 

a)        Test method

OIE Manual of Diagnostic Test and Vaccines for Terrestrial Animals, Chapter 3.5.10 (Version adopted in May 2013)

b)        Test type

 Serum

c)         Sample type

Quantitative

d)        Sample Volume/Amount

5 - 7 ml

e)        Sample submission

CVRL does not conduct site visit and sampling. Refer ‘CVRL- Guidelines’, section ‘’Sending a sample’’

f)         TAT

5 - 14 working days

g)        Results

Refer ‘CVRL- Guidelines’, section ‘’Results’’

h)        Measurement of Uncertainty (MU)

N/A

i)          Expression of result

Negative or Positive (positive serum is reported in titers)

j)         Cut off titers

Negative:  A titer < 1:4 is considered negative

Positive: A titer of 1:4 or greater is considered positive

Test: Equine Piroplasmosis (Babesia caballi + Theileria equi) - Immunofluorescence antibody test (IFAT)

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications

 

a)        Test method

OIE Manual of Diagnostic Test and Vaccines for Terrestrial Animals, Chapter 3.5.8 (Version adopted in May 2014)

b)        Test type

 Serum

c)         Sample type

Quantitative

d)        Sample Volume/Amount

5 - 7 ml

e)        Sample submission

CVRL does not conduct site visit and sampling. Refer ‘CVRL- Guidelines’, section ‘’Sending a sample’’

f)         TAT

4 - 5 working days

g)        Results

Refer ‘CVRL- Guidelines’, section ‘’Results’’

h)        Measurement of Uncertainty (MU)

N/A

i)          Expression of result

Negative, Positive (positive serum is reported in titers) or dubious

j)          Cut off titers

Negative:  A titer <1:80 is considered negative

Positive: A titer of 1:80+++ or greater is considered positive

Dubious:  A titer of 1:80+ or 1:80++

Test: MERS-Coronavirus (MERS - CoV) Isolation

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2021

Test specifications

 

a)        Test method

In-house Method

b)        Test type

Qualitative

c)         Sample type

Swab: Nasal

Tissues:  Lung and trachea

d)        Sample Volume/Amount

Swabs must be send in viral transport medium which can be collected from CVRL. Appropriate amount of  tissues/organs

e)        Sample submission

CVRL does not conduct site visit and sampling. Refer ‘CVRL- Guidelines’, section ‘’Sending a sample’’

f)         TAT

7 - 14 working days

g)        Results

Refer ‘CVRL- Guidelines’, section ‘’Results’’

h)        Measurement of Uncertainty (MU)

N/A

i)          Expression of result

Virus isolated or no virus isolated

 

© 2018 CVRL | Powered by whyIT Solutions